Daniella Beckman, Chief Financial Officer at Tango Therapeutics, Inc. (TNGX), sold 20,634 shares at $12.26 ($253K) on 2026-02-03, disclosed to the SEC on 2026-02-04.
Open-market sale of $253k TNGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.26 | 10,204 | $125K | 49.4% |
| 2 | $12.26 | 10,204 | $125K | 49.4% |
| 3 | $12.90 | 113 | $1K | 0.6% |
| 4 | $12.90 | 113 | $1K | 0.6% |
| Total | $12.27 avg | 20,634 | $253K | 100% |
| Filing → |